propidium has been researched along with donepezil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Küçükkilinç, T; Ozer, I | 1 |
| Bajda, M; Malawska, B; Musiał, A | 1 |
| Das, JR; Tizabi, Y | 1 |
1 review(s) available for propidium and donepezil
| Article | Year |
|---|---|
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine | 2007 |
2 other study(ies) available for propidium and donepezil
| Article | Year |
|---|---|
Inhibition of human plasma cholinesterase by malachite green and related triarylmethane dyes: mechanistic implications.
Topics: Binding Sites; Butyrylthiocholine; Choline; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Hydrogen-Ion Concentration; Indans; Kinetics; Ligands; Methyl Green; Peripheral Nerves; Phenothiazines; Piperidines; Propidium; Rosaniline Dyes; Temperature; Toluidines | 2005 |
Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.
Topics: Analysis of Variance; Annexin A5; Apoptosis; Atropine; Cell Cycle; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indans; Mecamylamine; Neuroblastoma; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Piperidines; Propidium; Salsoline Alkaloids | 2009 |